Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023

Rhea-AI Summary

Singular Genomics Systems, Inc. (Nasdaq: OMIC) will report financial results for Q3 2023 on November 14, 2023. The management will discuss the results during a conference call. Investors can listen to the call and access the webcast at investor.singulargenomics.com.

Positive

• Investors can gain insights into Singular Genomics Systems' financial performance for Q3 2023, which could positively impact the stock price.

Negative

• No negative takes found.

SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the third quarter 2023 after the market close on Tuesday, November 14, 2023. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing 1-888-506-0062 for domestic callers or 1-973-528-0011 for international callers and using conference ID 616134 approximately five minutes prior to the start time. A live and archived webcast of the event will be available at investor.singulargenomics.com, in the Presentations & Events section.

About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In addition, Singular Genomics commenced development of the PX system, which leverages Singular’s proprietary sequencing technology, applying it as an in situ readout to look at RNA and proteins in single cells and tissue. Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.

Investor Contact
Matt Clawson
949-370-8500
ir@singulargenomics.com

Media Contact
Dan Budwick, 1AB
973-271-6085
dan@1abmedia.com

FAQ

When will Singular Genomics Systems report financial results for Q3 2023?

Singular Genomics Systems will report financial results for Q3 2023 on November 14, 2023.

How can investors listen to the conference call?

Investors can listen to the conference call by dialing 1-888-506-0062 for domestic callers or 1-973-528-0011 for international callers and using conference ID 616134.

Where can investors access the webcast of the event?

Investors can access the webcast of the event at investor.singulargenomics.com, in the Presentations & Events section.